GENERAL COMMENTS
The objective is clear, they hypothesized that HCV-seropositive postmenopausal women had lower t-scores and higher Frax predicted fractures rates tan HCV-seronegative.
But I want to comment some sections: The second conclusion that early treat…… is a hypothesis not analyzed nor discussed at present work. I think the second conclusion may be …and a major risk of fractures predicted by FRAX.
-In Introduction they related co-infection with HIV, which is common in men but no, mentioned anything about coinfection with HVB.
-Women under 45 were excluded, then why appear in table 1 (40-64 years and >= 65 years) -In laboratory, I miss the determination of vitamin D, parathyroid hormone, calcium, phosphorus, albumin, and proteins.
-Bone Mineral Density would be expressed not only in t-score but on gr/cm2 -FRAX score assessment:
I think, would be better to expresses what means low, medium or high-risk ( which are the cut-offs used)
-I think the term Osteodistrophy is not adequately and is more convenient "composite osteopenia and osteoporosis " or low bone mass. Osteodistrophy could include more conditions. DISCUSSION -They discussed the paper of malnutrition on bone loss, but not reflected in the lab section: protein or albumin or any related item. Discussed about the effects of advanced cirrhosis, but those women are excluded at the present work. -And not always early osteopenia indicates risk of future osteoporosis.
LIMITATIONS
Limitations are important. Not only they have no information about calcium supplements or vitamin D. They not have information about vitamin D levels, duration of HCV infection, chronic o clear infection, HCV load, antiviral therapy. I don't understand why they mentioned non-steroidal antiinflammatory drug usage related to BMD values. The severity of liver disease partly explains the HCV-associated increase of osteoporotic fractures, may be associated with architecture changes beyond what can be assessed by BMD (DXA) that lead to increased bone fragility. Trabecular bone score or others could help to identify those patients.
CONCLUSION.
I think they cannot infer that early detection of hepatitis virus and aggressive antiviral therapy might offer extrahepàtic benefits for HCV-infected subjects.
VERSION 1 -AUTHOR RESPONSE
Thank you for your constructive recommendations -some changes have been made accordingly and labeled in red.
Reviewer: 1: Luciana Diniz Silva
Although the research question is important there are some points that have to be reviewed regarding this manuscript. Specific comments Response: Thanks for your kind recommend and we had corrected the errors in our introduction section. (Page 4, Line 11-13) References:
1.
World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. World Health Organization, 2016.
[2] Page 6, Line 03 -27: "Blood pressure and anthropometric measurements." Regarding the age range of individuals included in the study and the body mass index classification, were the elderly individuals classified according to the Lipschitz classification?
Response: Thanks your valuable opinion though enrolled participants aged between 40-80 years old. We reclassified again for under-weight group according to "Lipschitz classification" for those elder participant and add citation. Please see Table 1 and Table 2 . By Lipschitz classification, we also discuss about the relationship of lower BMI and osteoporosis or HCV seropositivity in our manuscript. (Page 6, 9, 17-18, Table 1 & 2)
[3] Page 8, Line 12 -14; statistics: Were the data distributed normally? If not, then perhaps medians would be better than means. Clarification should be provided for the statistical strategies adopted regarding the non-normal distribution of the data.
Response: Thanks for your comment. We have tested the normality of continuous variables using Kolmogorov-Smirnov test. Most of the null hypothesis were rejected except for waist to hip ratio, waist to height ratio, systolic blood pressure and total cholesterol. In order to make the presentation of data more consistent, data of all the continuous variables were presented as median and interquartile range and were compared between groups by using nonparametric statistics (i.e. Jonckheere-Terpstra test for trend across BMD groups or Mann-Whitney U test for comparing 2 groups). Table 1 and Table 2 Response: We had added those abbreviations below all tables. (Table 3) [7] In general, the discussion extrapolated the objective and findings of this study. The authors should be focused to their results, which should be discussed.
Response:
We have made an effort to discuss our results in the revised manuscript.
[8] Page 14, Discussion -In the beginning line 35 -41. Is the term "association" more appropriate than "correlation"?
Response: Thanks for your reminder, and we correct the term to "association". (Page 17, Line 9-13)
[9] Page 14, Discussion -45-49. "Those results suggest the need for antiviral therapy in HCV-positive, postmenopausal women to reduce the risk of potential fractures." However this process, i.e., the bone wasting might begin in earlier phases. Then, the authors believe that only postmenopausal women should be treated. Clarification should be provided for this matter. See also, page 16, line 36 -41.
We agreed with reviewer's concern about bone wasting might begin in earlier phases. Therefore, we have modified the sentence and deleted "postmenopausal". (Page 17)
[10] Page 15, Discussion -1-50. The authors wrote about the implications of liver cirrhosis in the BMI and malnutrition, nevertheless, liver cirrhosis was one of the exclusion criteria of this study. In addition, is the BMI appropriate to accurately differentiate between important body weights components?
[ Response: We appreciated reviewer's recommend. Those subjects with lower body weights and BMIs tended to have dyspepsia, nutrition deficiency, gastric disorders, or hepatic cachexia. BMI and weight might be closely correlated to body fat content. BMD was positively correlated to BMI and weight, while TBS was negatively correlated to BMI and weight. Therefore, although higher BMI causes an increase in BMD, it appears to be negatively affecting bone quality. We would add the reference and information as "BMI, as the traditional tool for assessing malnutrition and obesity, is not appropriate to accurately differentiate between important body weight components" into our discussion section. (Page 18, Line 10-19)
Reviewer: 2: Zhifeng Sheng
This is an interesting study since few studies have reported the HCV infection associated with bone health especially in Chinese. The text was structured very well throughout the whole manuscript. I have several comments on this study.
[1] The prevalence of HCV seropositive in the population looks high. The author should specify the detail of the recruitments of the subjects and explain why.
Response:
The prevalence of HCV infection has been determined to be 1% to 3% in Taiwan, whereas it is as high as 6% to 30% in southern Taiwan specifically [1, 2] . Therefore, we attempted to analyze community-based screening data adjusted for the demographic, metabolic, and liver profiles of patients from Mailiao, Taiwan-an area hyperendemic for HBV and HCV infections. (Page 4, Line 11-14)
[2] Moreover, it was showed that the HCV seropositive patients had higher blood glucose, blood pressure and abnormal lipids comparing with those HCV seronegative. These may attribute to the impact of HCV. The author should comment the relationship of HCV role on both metabolic detriments and bone health, best doing further statistical analysis to show the real correlation if possible.
Response: We partly agree with your opinion which the HCV seropositive patients had higher fasting sugar, blood pressure and abnormal lipids while these metabolic detriments may also correlated to bone health. However, observed from Table 1 , there were no significant differences of fasting sugar, blood pressure and abnormal lipids among the 3 groups by bone mineral density. Therefore, those metabolic disturbances might play a role in the association between HCV and bone health. We focus on nutrition associated factors affecting BMD loss in "discussion" section. (Page 18, Line 10-14)
Specific comments:
[3] Page 6. Line 15. The author should tell us why premature menopause was defined as age before 45 yrs.
Response: Early menopause means age between 40~45 and premature menopause means age before 40 years-old. We had corrected the mistake and errors. (Page 5, Line 7-9)
[4] Page 7. Line 10 "Z-sore" should be deleted.
Response: "Z-score" was deleted according to reviewer's kind reminder. (Page 8)
[5] Page 10. Line 11 Table 1 . Age should be 45-64 yrs not 40-64 yrs since the participants with age under 45 yrs were excluded as the author mentioned before.
Response: We had correct that premature menopause means age before 40 years-old. (Table 1) [6] Table 1 All the significant P value should be marker.
We agreed your opinion and add markers "*" for significant P values in all tables. (Table 1- 
3)

Reviewer: 3: Cristina carbonell-abella
The objective is clear, they hypothesized that HCV-seropositive postmenopausal women had lower tscores and higher Frax predicted fractures rates tan HCV-seronegative. But I want to comment some sections:
[1] The second conclusion that early treat…… is a hypothesis not analyzed nor discussed at present work. I think the second conclusion may be …and a major risk of fractures predicted by FRAX.
Response:
We had corrected this sentence according to our study result and focus on "fractures predicted by FRAX". (Page 3, Line 3-4)
[2] In Introduction they related co-infection with HIV, which is common in men but no, mentioned anything about coinfection with HBV.
Response: Among patients with chronic liver diseases, the HBV carrier rate was even higher than 80 percent in Taiwan. HCV superinfection in patients with chronic HBV infection was the most common clinical features of coinfection in Asia-Pacific countries [1] . Schiefke and his colleges showed that there was a significantly reduced BMD in non-cirrhotic patients with chronic hepatitis B or C infection [2] . We had mentioned the information and added associated reference in our introduction section. [4] In laboratory, I miss the determination of vitamin D, parathyroid hormone, calcium, phosphorus, albumin, and proteins.
In health screening program, we checked albumin and total protein, but not vitamin D, parathyroid hormone, calcium, phosphorus. We had added the essential information and re-analyzed the all data. (Page 9, Table 1 and Table 2) [5] Bone Mineral Density would be expressed not only in t-score but on gr/cm2
Response: Thanks for your useful recommendation. The bone mineral density could be expressed in both units; however, we check FRAX by t-score according to DEX references. The extent of bone mass reduction is accurately measured by the dual X-ray absorptiometry (DXA)-determined BMD value at a specific site (traditionally the femoral neck), and is expressed as the T-score. The WHO defines osteoporosis as a T-score at the hip or lumbar spine ≤ −2.5 SD below the average value for young women aged 20-29. Fracture risk has been determined to a large extent by the T-score, although it is recognized that the BMD alone lacks sensitivity in predicting individual risk. (Page 8, Line 2; Table 2) [6] FRAX score assessment: I think, would be better to expresses what means low, medium or highrisk (which are the cut-offs used)
Response: We had added the cut-offs value in "method section" and figure legend. (Page 7, Line 16-20)
[7] I think the term Osteodistrophy is not adequately and is more convenient "composite osteopenia and osteoporosis" or low bone mass. Osteodistrophy could include more conditions.
Response: That's a serious recommend and we must avoid the erroneous term in the manuscript. We have deleted the term "osteodystrophy" throughout the text.
[8] They discussed the paper of malnutrition on bone loss, but not reflected in the lab section: protein or albumin or any related item. Discussed about the effects of advanced cirrhosis, but those women are excluded at the present work.
We had added the essential information and re-analyzed the all data (Table 1 and Table  2 ). We also made an effort to enhance discussion in our manuscript. (Page 19, Line 1-11)
[9] And not always early osteopenia indicates risk of future osteoporosis.
Response: Early osteopenia should be cautious in any disease and health promoting program. However, we agree with your opinion well and corrected the sentence in our manuscript. I don't understand why they mentioned non-steroidal anti-inflammatory drug usage related to BMD values.
Response: Thanks for your helpful reminder. Although, NSAIDs are supposed to reduce the rate of bone loss, and thus improve bone mineral density (BMD) and prevent a fragility hip fracture [1, 2] , but conflicting results have also been published [3] . Additional analyses that use different approaches to control for confounding are necessary to clarify the degree of association and/or causal link between NSAIDs and the risk of a second hip fracture. In human medicine NSAID are known to prevent heterotopic ossification, however the clinical importance of their effects on bone healing remains controversial. Therefore, we have deleted the information and sentences in the limitation section. (Page 20 limitation)
[11] The severity of liver disease partly explains the HCV-associated increase of osteoporotic fractures, may be associated with architecture changes beyond what can be assessed by BMD (DXA) that lead to increased bone fragility. Trabecular bone score or others could help to identify those patients.
The trabecular bone score (TBS) is a new texture parameter obtained from the analysis of dual-energy X-ray absorptiometry (DXA) images [1] . New tools to assess bone quality, including the trabecular bone score, high-resolution peripheral quantitative computed tomography, and in-vivo microindentation, may help improve understanding of the mechanisms of HCV-associated skeletal fragility. TBS could be used for accurate bone quality analysis and correlated with FRAX-base predicted fracture [2] ; however, we can't apply the measurement in our current equipment. Therefore, we would mention this in our "limitation" section. ( 
CONCLUSION.
[12] I think they cannot infer that early detection of hepatitis virus and aggressive antiviral therapy might offer extrahepàtic benefits for HCV-infected subjects.
Response: We agree with your opinion. The impact of approved interferon based therapy and directacting antivirals for the treatment of chronic HCV infection on patients' bone health remain to be studied [1, 2] . However, we could not confirm the potential effect of AVT on osteoporotic fracture in our study. Therefore, we have deleted this inappropriate sentence in "conclusion" section. 
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GENERAL COMMENTS Dear authors,
In the discussion, page 19, lines 7-10, the sentences should be rewritten because they are not clear. This information should be better elaborated. "Despite the exclusion of cirrhotic patients in our study and a part (not all subjects) of HCV soropositive subjects might have lesser degrees of fibrosis or cirrhosis, our findings demonstrated that chronic HCV infection tends to be.
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GENERAL COMMENTS
No comments any more. In the discussion, page 19, lines 7-10, the sentences should be rewritten because they are not clear. This information should be better elaborated. "Despite the exclusion of cirrhotic patients in our study and a part (not all subjects) of HCV soropositive subjects might have lesser degrees of fibrosis or cirrhosis, our findings demonstrated that chronic HCV infection tends to be ..... 
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